Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06616831 · ClinicalTrials.gov registry record · NA

At-Home taVNS - Stroke Rehab

A NA study of Stroke and Stroke, Ischemic, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT06616831: Recruiting NA study of Stroke and Stroke, Ischemic, sponsored by Medical University of South Carolina.

NCT06616831 is a NA study of Stroke and Stroke, Ischemic that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 5 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06616831, a NA study of Stroke and Stroke, Ischemic, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

Early evidence suggests the benefits of post-stroke motor rehabilitation may be enhanced by applying electrical stimulation to the ear. This study aims to test the new approach of pairing ear stimulation with motor rehabilitation in the home setting in stroke survivors with upper limb motor function deficits.

Primary Outcome

Dropout rates will be assessed over the course of the study.

Interventions

  • DEVICE Remote Transcutaneous Auricular Vagal Nerve Stimulation Paired with Task-Specific Training

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2024-10-28
Est. Completion 2026-09-30
Phase NA

What NCT06616831 shows while recruiting

NCT06616831 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Remote Transcutaneous Auricular Vagal Nerve Stimulation Paired with Task-Specific Training is the first listed.

NCT06616831 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT06616831 about?

NCT06616831 is a clinical study titled "At-Home taVNS - Stroke Rehab". Early evidence suggests the benefits of post-stroke motor rehabilitation may be enhanced by applying electrical stimulation to the ear. This study aims to test the new approach of pairing ear stimulation with motor rehabilitation in the home setting in stroke survivors with upper limb motor function...

What is the current status of trial NCT06616831?

This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2024-10-28. Estimated completion is 2026-09-30.

What conditions does trial NCT06616831 study?

This clinical trial studies the following conditions: Stroke, Stroke, Ischemic, Stroke Hemorrhagic.

What interventions are being tested in trial NCT06616831?

The interventions under investigation include: Remote Transcutaneous Auricular Vagal Nerve Stimulation Paired with Task-Specific Training (DEVICE).

Who is sponsoring clinical trial NCT06616831?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06616831 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06616831's enrollment target sits among peer trials

5 439th of 454 higher than 11 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06616831, the US trial registry maintained by the National Library of Medicine. NCT06616831 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.